CLINICAL TRIALS PROFILE FOR FAMOTIDINE; IBUPROFEN
✉ Email this page to a colleague
All Clinical Trials for famotidine; ibuprofen
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT00450216 ↗ | Efficacy and Safety Study of HZT-501 in Subjects Requiring Nonsteroidal Anti-Inflammatory Drug (NSAID) Treatment | Completed | Horizon Pharma Ireland, Ltd., Dublin Ireland | Phase 3 | 2007-03-01 | The purpose of this study is to evaluate whether HZT-501 is effective in reducing the rate of development of ibuprofen-associated ulcers in patients who require long-term daily use of ibuprofen. |
NCT00450658 ↗ | Efficacy and Safety Study of HZT-501 in Reducing the Risk of Ibuprofen-associated Ulcers | Completed | Horizon Pharma Ireland, Ltd., Dublin Ireland | Phase 3 | 2007-03-01 | The purpose of this study is to evaluate whether HZT-501 is effective in reducing the rate of development of ibuprofen-associated ulcers in patients who require long-term daily use of ibuprofen. |
NCT00613106 ↗ | Double-Blind Follow-on Safety Study of HZT-501 (Ibuprofen 800 mg/Famotidine 26.6 mg) in Subjects Who Have Completed Participation in HZ-CA-301 (NCT00450658) or HZ-CA-303 (NCT00450216) | Completed | Horizon Pharma Ireland, Ltd., Dublin Ireland | Phase 3 | 2007-09-01 | The purpose of this study is to evaluate the safety of long-term treatment with HZT-501. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for famotidine; ibuprofen
Condition Name
Clinical Trial Locations for famotidine; ibuprofen
Trials by Country
Clinical Trial Progress for famotidine; ibuprofen
Clinical Trial Phase
Clinical Trial Sponsors for famotidine; ibuprofen
Sponsor Name